Inflammatory Process Modulation by Homeopathic Arnica montana 6CH: The Role of Individual Variation

Table 6

General view of results obtained in rats that developed spontaneous peak of oedema between 30 and 180 minutes (late oedema subgroup) after the injection of 1% carrageenan into the footpad. *Kruskal-Wallis, 𝑃≤.05; **ANOVA, 𝑃=.01; ^#𝑋², 𝑃=.0001 in relation to control.

Late oedema subgroup	Control (vehicle)	Arnica montana 6cH	Dexamethasone (4 mg/kg)
Paw oedema (180 min)	0.84±0.33^a	0.07±0.48^∗∗	0.51±0.55
Degranulated mast cells	24%	17%^#	16%^#
Lymphatic vessels diameter	108.73±65.34^b	147.32±113.71^∗	80.13±44.64
CD 54	4 (2–7)^c	4.5 (2–6)	2 (2–5)
PMN	176.33±29.95^d	185.60±17.16	179.37±22.67
CD45RA	22.85±17.12	22.77±16.20	25.88±20.27
CD18	62±13.68	56.8±23.58	63.11±18.82
CD163	31.5±14.84	35.66±10.34	30.11±12.45
MAC 387	47.77±8.24	45.2±11.53	51.88±13.52
CD3	12.66±7.98	15.2±7.50	14.88±5.37
CD163/MAC387ratio	0.60	0.50	0.66

^amean ± standard deviation; millimeters.
^bmean ± standard deviation; pixels per field.
^cmedian and interval; scores attributed by two independent observers.
^dmean ± standard deviation; cells per field.